Han Koh
Impact in
- Oncology top 1%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
- Pulmonary and Respiratory Medicine top 0.5%
- Advanced Breast Cancer Therapies
Papers in
-
- Advanced Breast Cancer Therapies 12
- Lung Cancer Treatments and Mutations 5
- Oncology 14
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 4
- Lung Cancer Research Studies 3
- Co-authors
- George W. Sledge (10 shared papers)Antonio Llombart‐Cussac (10 shared papers)Eva‐Maria Grischke (9 shared papers)Joohyuk Sohn (9 shared papers)Kenichi Inoue (8 shared papers)Meena Okera (9 shared papers)Masakazu Toi (9 shared papers)Norikazu Masuda (9 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Clinical Cancer Research (2 papers)Blood (2 papers)Annals of Oncology (2 papers)Breast Cancer Targets and Therapy (1 paper)
- Partner nations
- United StatesSpainJapan
In The Last Decade
Han Koh
26 papers receiving 2.9k citations
Han Koh's Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 1.6k
- Pulmonary and Respiratory Medicine 1.8k
- Cancer Research 517
- Genetics 311
- Cell Biology 75
Countries citing papers authored by Han Koh
This map shows the geographic impact of Han Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Koh more than expected).
Fields of papers citing papers by Han Koh
This network shows the impact of papers produced by Han Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Koh. The network helps show where Han Koh may publish in the future.
Co-authors
The 25 scholars most cited alongside Han Koh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy Hit paper breakdown → | 2017 | 1145 |
| 2 | Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study Hit paper breakdown → | 2011 | 817 |
| 3 | The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2 Hit paper breakdown → | 2019 | 629 |
| 4 | 2016 | 62 | |
| 5 | 2021 | 43 | |
| 6 | 2015 | 41 | |
| 7 | 2018 | 40 | |
| 8 | 2016 | 26 | |
| 9 | 2014 | 23 | |
| 10 | 2019 | 17 | |
| 11 | 2016 | 16 | |
| 12 | 2017 | 11 | |
| 13 | 2023 | 11 | |
| 14 | 2017 | 10 | |
| 15 | 2017 | 8 | |
| 16 | 2016 | 8 | |
| 17 | 2021 | 7 | |
| 18 | 2020 | 4 | |
| 19 | 1996 | 4 | |
| 20 | 2023 | 2 |
About Han Koh
Han Koh is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Hematology and Cancer Research, having authored 28 papers that have together received 2.9k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (12 papers), Cancer Treatment and Pharmacology (7 papers), Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), HER2/EGFR in Cancer Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (1.6k citations), Pulmonary and Respiratory Medicine (1.8k citations), Cancer Research (517 citations), Genetics (311 citations) and Cell Biology (75 citations). Han Koh has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include George W. Sledge, Antonio Llombart‐Cussac, Eva‐Maria Grischke, Joohyuk Sohn, Kenichi Inoue, Meena Okera, Masakazu Toi, Norikazu Masuda, Patrick Neven and Peter A. Kaufman. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Blood, Annals of Oncology and Breast Cancer Targets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.